Skip to Main Content

Paper Details

Metformin delays AKT/c-Met-driven hepatocarcinogenesis by regulating signaling pathways for de novo lipogenesis and ATP generation.
Toxicol Appl Pharmacol
13
2019
Author NameAffiliation
Liang ChenHubei University of Chinese Medicine
  • 1 - 1

Datasets

Release 1.2